EXECUTIVE SUMMARY -

Clinical trials are a lifesaving option for many cancer patients. But too many patients face barriers preventing access to this critical treatment.

Everyone suffers when patients cannot access clinical trials. Today’s patients miss out on potentially lifesaving treatments, and future patients may not gain access to newer, potentially better treatments as quickly as they could have, otherwise.

Originally Published by the Leukemia & Lymphoma Society (LLS).